Project Abstracts - HPAP, HPAC

Ali Naji, MD, PhD, Investigator, University of Pennsylvania
Ben Voight, PhD, Investigator, University of Pennsylvania
Doris Stoffers, MD, PhD, co-Investigator, University of Pennsylvania
Jason Moore, PhD, co-Investigator, University of Pennsylvania (09/2019-11/2021)
Michael Feldman, MD, PhD, co-Investigator, University of Pennsylvania (09/2019 – 03/2023)
Babak Faryabi, PhD, co-Investigator, University of Pennsylvania (11/2021-present)

Start Date: September 30, 2019

---

Abstract

The past decades have seen a dramatic improvement in our ability to phenotype and molecularly profile human tissues relevant to the etiology of type 2 diabetes with unprecedented resolution, at the genomic, epigenomic, protein, and functional levels.  Here we will employ state-of-the-art technologies to determine all aspects of pancreas biology as it pertains to type 2 diabetes, profile human pancreatic islets with multiple assay modalities, and make the vast data accumulated available through the highly accessible PANC-DB. This comprehensive profiling of the natural history of Type 2 diabetes will pave the way for future discoveries of new treatment modalities for diabetes.

 

Meet the Grant Team

Investigators

Klaus Kaestner, PhD University of Pennsylvania	Ali Naji, MD, PhD University of Pennsylvania	Ben Voight, PhD University of Pennsylvania
Doris Stoffers, MD, PhD University of Pennsylvania	Jason Moore, PhD University of Pennsylvania	Michael Feldman, MD, PhD University of Pennsylvania

Publications

• DNA methylation-based assessment of cell composition in human pancreas and islets
• RFX6 maintains gene expression and function of adult human islet α cells
• Exocrine pancreas in type 1 and type 2 diabetes: different patterns of fibrosis, metaplasia, angiopathy, and adiposity
• Benchmarking algorithms for joint integration of unpaired and paired single-cell RNA-seq and ATAC-seq data
• The leptin receptor has no role in delta-cell control of beta-cell function in the mouse
• An Integrated Map of Cell Type-Specific Gene Expression in Pancreatic Islets
• Pericyte dysfunction and impaired vasomotion are hallmarks of islets during the pathogenesis of type 1 diabetes
• Inferring regulators of cell identity in the human adult pancreas
• An integrated map of cell type-specific gene expression in pancreatic islets
• AnnoSpat annotates cell types and quantifies cellular arrangements from spatial proteomics
• Understanding islet dysfunction in type 2 diabetes through multidimensional pancreatic phenotyping: The Human Pancreas Analysis Program
• Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress
• 3D chromatin maps of the human pancreas reveal lineage-specific regulatory architecture of T2D risk
• Adaptation to chronic ER stress enforces pancreatic β-cell plasticity
• α Cell dysfunction in islets from nondiabetic, glutamic acid decarboxylase autoantibody-positive individuals
• Variant-to-gene-mapping analyses reveal a role for pancreatic islet cells in conferring genetic susceptibility to sleep-related traits
• Limited extent and consequences of pancreatic SARS-CoV-2 infection
• Islet Lymphocytes Maintain a Stable Regulatory Phenotype Under Homeostatic Conditions and Metabolic Stress
• Single-cell analysis of the human pancreas in type 2 diabetes using multi-spectral imaging mass cytometry
• What is a β cell? – Chapter I in the Human Islet Research Network (HIRN) Review Series
• Pancreatic islet reserve in type 1 diabetes
• SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 Are Expressed in the Microvasculature and Ducts of Human Pancreas but Are Not Enriched in β Cells